Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Trillium Therapeutics Q2 EPS $(0.18) Up From $(0.28) YoY

Trillium Therapeutics (NASDAQ:TRIL) reported quarterly losses of $(0.18) per share. This is a 35.71 percent increase over losses of $(0.28) per share from the same period last year.

byBill Haddad

August 13, 2021

1 minute read

Trillium Therapeutics (NASDAQ:TRIL) reported quarterly losses of $(0.18) per share. This is a 35.71 percent increase over losses of $(0.28) per share from the same period last year.

Ballys Q2 Adj. EPS $0.48 Beats $0.46 Estimate, Sales $267.70M Beat $225.36M Estimate

By Bill Haddad

Today, 5:10 AM

Ballys (NYSE:BALY) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.46 by 4.35 percent. This is a 160.76 percent increase over losses of $(0.79) per share from the same

BALY

Soleno Therapeutics’ DCCR Shows Benefit On Hunger, Behavioral Parameters

By Vandana Singh

Today, 5:10 AM

Soleno Therapeutics Inc (NASDAQ:SLNO) has announced top-line results from its ongoing open-label extension study evaluating DCCR (Diazoxide Choline) Extended-Release tablets for…

SLNO

AIG Files $20B IPO For Its Life Insurance & Asset Management Business

By Vandana Singh

Today, 5:10 AM

American International Group Inc (NYSE: AIG) has filed for an initial public offering of its life and asset management business, reportedly by far the largest to file for a US IPO this year publicly.

AIG